Copyright Reports & Markets. All rights reserved.

Global Dolutegravir Market Status and Forecast 2021-2027

Request for Sample of this report
Buy now

Table of Contents

    1 Product Introduction and Overview

    • 1.1 Product Definition
    • 1.2 Product Specification
    • 1.3 Global Market Overview
      • 1.3.1 Global Dolutegravir Market Status and Forecast (2016-2027)
      • 1.3.2 Global Dolutegravir Sales Value CAGR by Region
    • 1.4 Market Drivers, Inhibitors
      • 1.4.1 Market Drivers
      • 1.4.2 Market Inhibitors
      • 1.4.3 COVID-19 Impact Analysis

    2 Global Dolutegravir Supply by Company

    • 2.1 Global Dolutegravir Sales Volume by Company
    • 2.2 Global Dolutegravir Sales Value by Company
    • 2.3 Global Dolutegravir Price by Company
    • 2.4 Dolutegravir Production Location and Sales Area of Main Manufacturers
    • 2.5 Trend of Concentration Rate

    3 Global and Regional Dolutegravir Market Status by Type

    • 3.1 Dolutegravir Type Introduction
      • 3.1.1 10mg Tablets
      • 3.1.2 50mg Tablets
    • 3.2 Global Dolutegravir Market by Type
      • 3.2.1 Global Dolutegravir Sales Volume by Type (2016-2021)
      • 3.2.2 Global Dolutegravir Sales Value by Type (2016-2021)
      • 3.2.3 Global Dolutegravir Price by Type (2016-2021)
    • 3.3 North America: by Type
    • 3.4 Europe: by Type
    • 3.5 Asia Pacific: by Type
    • 3.6 Central & South America: by Type
    • 3.7 Middle East & Africa: by Type

    4 Global and Regional Dolutegravir Market Status by Application

    • 4.1 Dolutegravir Segment by Application
      • 4.1.1 Prevent HIV Infection Following Potential Exposure
      • 4.1.2 Other
    • 4.2 Global Dolutegravir Market by Application
      • 4.2.1 Global Dolutegravir Sales Volume by Application (2016-2021)
      • 4.2.2 Global Dolutegravir Sales Value by Application (2016-2021)
      • 4.2.3 Global Dolutegravir Price by Application (2016-2021)
    • 4.3 North America: by Application
    • 4.4 Europe: by Application
    • 4.5 Asia Pacific: by Application
    • 4.6 Central & South America: by Application
    • 4.7 Middle East & Africa: by Application

    5 Global Dolutegravir Market Status by Region

    • 5.1 Global Dolutegravir Market by Region
      • 5.1.1 Global Dolutegravir Sales Volume by Region
      • 5.1.2 Global Dolutegravir Sales Value by Region
    • 5.2 North America Dolutegravir Market Status
    • 5.3 Europe Dolutegravir Market Status
    • 5.4 Asia Pacific Dolutegravir Market Status
    • 5.5 Central & South America Dolutegravir Market Status
    • 5.6 Middle East & Africa Dolutegravir Market Status

    6 North America Dolutegravir Market Status

    • 6.1 North America Dolutegravir Market by Country
      • 6.1.1 North America Dolutegravir Sales Volume by Country (2016-2021)
      • 6.1.2 North America Dolutegravir Sales Value by Country (2016-2021)
    • 6.2 United States
    • 6.3 Canada
    • 6.4 Mexico

    7 Europe Dolutegravir Market Status

    • 7.1 Europe Dolutegravir Market by Country
      • 7.1.1 Europe Dolutegravir Sales Volume by Country (2016-2021)
      • 7.1.2 Europe Dolutegravir Sales Value by Country (2016-2021)
    • 7.2 Germany
    • 7.3 France
    • 7.4 UK
    • 7.5 Italy
    • 7.6 Russia
    • 7.7 Spain

    8 Asia Pacific Dolutegravir Market Status

    • 8.1 Asia Pacific Dolutegravir Market by Country
      • 8.1.1 Asia Pacific Dolutegravir Sales Volume by Country (2016-2021)
      • 8.1.2 Asia Pacific Dolutegravir Sales Value by Country (2016-2021)
    • 8.2 China
    • 8.3 Japan
    • 8.4 Korea
    • 8.5 Southeast Asia
    • 8.6 India
    • 8.7 Australasia

    9 Central & South America Dolutegravir Market Status

    • 9.1 Central & South America Dolutegravir Market by Country
      • 9.1.1 Central & South America Dolutegravir Sales Volume by Country (2016-2021)
      • 9.1.2 Central & South America Dolutegravir Sales Value by Country (2016-2021)
    • 9.2 Brazil
    • 9.3 Argentina
    • 9.4 Colombia

    10 Middle East & Africa Dolutegravir Market Status

    • 10.1 Middle East & Africa Dolutegravir Market by Country
      • 10.1.1 Middle East & Africa Dolutegravir Sales Volume by Country (2016-2021)
      • 10.1.2 Middle East & Africa Dolutegravir Sales Value by Country (2016-2021)
    • 10.2 Iran
    • 10.3 Israel
    • 10.4 Turkey
    • 10.5 South Africa
    • 10.8 Saudi Arabia

    11 Supply Chain and Manufacturing Cost Analysis

    • 11.1 Supply Chain Analysis
    • 11.2 Production Process Chart Analysis
    • 11.3 Raw Materials and Key Suppliers Analysis
      • 11.3.1 Raw Materials Introduction
      • 11.3.2 Raw Materials Key Suppliers List
    • 11.4 Dolutegravir Manufacturing Cost Analysis
    • 11.5 Dolutegravir Sales Channel and Distributors Analysis
      • 11.5.1 Dolutegravir Sales Channel
      • 11.5.2 Dolutegravir Distributors
    • 11.6 Dolutegravir Downstream Major Buyers

    12 Global Dolutegravir Market Forecast by Type and by Application

    • 12.1 Global Dolutegravir Sales Volume and Sales Value Forecast (2022-2027)
    • 12.2 Global Dolutegravir Forecast by Type
      • 12.2.1 Global Dolutegravir Sales Volume Forecast by Type
      • 12.2.2 Global Dolutegravir Sales Value Forecast by Type
      • 12.2.3 Global Dolutegravir Price Forecast by Type
    • 12.3 Global Dolutegravir Forecast by Application
      • 12.3.1 Global Dolutegravir Sales Volume Forecast by Application
      • 12.3.2 Global Dolutegravir Sales Value Forecast by Application
      • 12.3.3 Global Dolutegravir Price Forecast by Application

    13 Global Dolutegravir Market Forecast by Region/Country

    • 13.1 Global Dolutegravir Market Forecast by Region (2022-2027)
      • 13.1.1 Global Dolutegravir Sales Volume Forecast by Region (2022-2027)
      • 13.1.2 Global Dolutegravir Sales Value Forecast by Region (2022-2027)
    • 13.2 North America Market Forecast
    • 13.3 Europe Market Forecast
    • 13.4 Asia Pacific Market Forecast
    • 13.5 Central & South America Market Forecast
    • 13.6 Middle East & Africa Market Forecast

    14 Key Participants Company Information

    • 14.1 ViiV Healthcare (GSK)
      • 14.1.1 Company Information
      • 14.1.2 Dolutegravir Product Introduction
      • 14.1.3 ViiV Healthcare (GSK) Dolutegravir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.1.4 SWOT Analysis
    • 14.2 Shanghai Desano Pharmaceuticals
      • 14.2.1 Company Information
      • 14.2.2 Dolutegravir Product Introduction
      • 14.2.3 Shanghai Desano Pharmaceuticals Dolutegravir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.2.4 SWOT Analysis
    • 14.3 Mylan
      • 14.3.1 Company Information
      • 14.3.2 Dolutegravir Product Introduction
      • 14.3.3 Mylan Dolutegravir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.3.4 SWOT Analysis
    • 14.4 LAURUS Labs
      • 14.4.1 Company Information
      • 14.4.2 Dolutegravir Product Introduction
      • 14.4.3 LAURUS Labs Dolutegravir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.4.4 SWOT Analysis
    • 14.5 Aurobindo Pharma
      • 14.5.1 Company Information
      • 14.5.2 Dolutegravir Product Introduction
      • 14.5.3 Aurobindo Pharma Dolutegravir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.5.4 SWOT Analysis
    • 14.6 Adcock Ingram Limited
      • 14.6.1 Company Information
      • 14.6.2 Dolutegravir Product Introduction
      • 14.6.3 Adcock Ingram Limited Dolutegravir Sales Volume, Price, Sales Value and Gross Margin (2019-2021)
      • 14.6.4 SWOT Analysis

    ...

      15 Conclusion

        16 Methodology

        This report provides a comprehensive analysis of current global Dolutegravir market based on segmented types and downstream applications. Major product development trends are discussed under major downstream segment scenario. This report also focuses on major driving factors and inhibitors that affect the market and competitive landscape. Global and regional leading players in the Dolutegravir industry are profiled in a detailed way, with sales data and market share info. This report also includes global and regional market size and forecast, drill-down to top 20 economies.

        According to this survey, the global Dolutegravir market is estimated to have reached $ xx million in 2020, and projected to grow at a CAGR of xx% to $ xx million by 2027.

        Covid-19 pandemic has impacted the supply and demand status for many industries along the supply chain. Global Dolutegravir Market Status and Forecast 2021-2027 report makes a brilliant attempt to unveil key opportunities available in the global Dolutegravir market under the covid-19 impact to help readers in achieving a better market position. No matter the client is industry insider, potential entrant or investor, the report will provide useful data and information.

        The Global Dolutegravir Market has been exhibited in detail in the following chapters
        Chapter 1 displays the basic product introduction and market overview.
        Chapter 2 provides the competition landscape of global Dolutegravir industry.
        Chapter 3 provides the market analysis by type and by region
        Chapter 4 provides the market analysis by application and by region
        Chapter 5-10 presents regional and country market size and forecast, under the context of market drivers and inhibitors analysis.
        Chapter 11 analyses the supply chain, including process chart introduction, upstream key raw material and cost analysis, distributor and downstream buyer analysis.
        Chapter 12 provides the market forecast by type and by application
        Chapter 13 provides the market forecast by region
        Chapter 14 profiles global leading players with their revenue, market share, profit margin, major product portfolio and SWOT analysis.
        Chapter 15 conclusions

        Segmented by Type
        10mg Tablets
        50mg Tablets

        Segmented by Application
        Prevent HIV Infection Following Potential Exposure
        Other

        Segmented by Country
        North America
        United States
        Canada
        Mexico
        Europe
        Germany
        France
        UK
        Italy
        Russia
        Spain
        Asia Pacific
        China
        Japan
        Korea
        Southeast Asia
        India
        Australasia
        Central & South America
        Brazil
        Argentina
        Colombia
        Middle East & Africa
        Iran
        Israel
        Turkey
        South Africa
        Saudi Arabia

        Key manufacturers included in this survey
        Mylan
        LAURUS Labs
        Aurobindo Pharma
        Adcock Ingram Limited
        Buy now